Usefulness of a colorimetric method for testing antifungal drug susceptibilities of Aspergillus species to voriconazole

Journal of Infection and Chemotherapy

Volumn 8, Issue 4, 2002, Pages 374-377

  Yamaguchi, Hideyo ^a   Uchida, Katsuhisa ^a   Nagino, Kenji ^b   Matsunaga, Toshiyuki ^b  

^a TEIKYO UNIVERSITY   (Japan)

^b PFIZER INC   (United States)

Author keywords

Alamar Blue; Antifungal susceptibility testing; Aspergillus species; Voriconazole

Indexed keywords

ALAMAR BLUE; AMPHOTERICIN B; FLUCYTOSINE; ITRACONAZOLE; UNCLASSIFIED DRUG; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS NIGER; COLORIMETRY; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

EID: 0036938029     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-002-0201-y     Document Type: Article

References (15)

1. McGinnis MR, Pasarell L, Sutton DA, Fothergill AW, Cooper CR, Rinaldi MG. In vitro evaluation of voriconazole against some clinically important fungi. Antimicrob Agents Chemother 1997;41:1832-4.
2. Espinel-Ingroff A. In vitro activity of the new triazole voriconazole (UK-109, 496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J Clin Microbiol 1998;36:198-202.
3. Johnson EM, Szekely A. Warnock DW: In vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J Antimicrob Chemother 1998;42:741-5.
4. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi; proposed standard. Document M38-P, Wayne, PA: National Committee for Clinical Laboratory Standards; 1998.
5. Jahn B, Martin E, Stueben A, Bhakdi S. Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay. J Clin Microbiol 1995;33:661-7.
6. Meletiadis J, Meis JFGM. Mouton JW, Donnelly JP, Verweij PE. Comparison of NCCLS and 3-(4,5-dimethyl-2-Thiazyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method. J Clin Microbiol 2000;38:2949-54.
7. Sánchez-Sousa A, Alvarez ME, Maiz L, Escobar H, Baquero F. Aspergillus fumigatus susceptibility testing by colorimetric microdilution. J Mycol Med 1999;9:103-6.
8. Hawser SP, Norris H, Jessup CJ, Ghannoum MA. Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-(phenylamino) carbonyl]-2H-tetrazolium hydroxide (XTT) colorimetric method with the Standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol 1998;36:1450-2.
9. 3H]thymidine incorporation assay. J Immunol Methods 1994;170:211-24.
10. Pfaller MA, Vu Q, Lancaster M, Espinel-Ingroff A, Fothergill A, Grant C, et al. Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J Clin Microbiol 1994;32:1625-8.
11. Report of the Standardization Committee of the Japanese Society of Medical Mycology 1995-1997. Jpn J Med Mycol 1999;40:243-6.
12. Wagner GE, Shadomy S. Studies on the mode of action of 5-fluorocytosine in Aspergillus species. Chemotherapy 1979;25:61-9.
13. Khoo TK, Sugai K, Leong TK. Disseminated aspergillosis. Case report and review of the world literature. Am J Clin Pathol 1966:45:697-703.
14. Vandevelde AG, Mauceri AA. Johnson JE 3rd. 5-fluorocytosine in the treatment of mycotic infections. Ann Intern Med 1972;77:43- 51.
15. Atkinson GW, Israel HL. 5-Fluorocytosine treatment of meningeal and pulmonary aspergillosis. Am J Med 1973;55:496-504.